Abstract
Type 2 Diabetes Mellitus (T2DM) is a chronic and epidemic disease with high socio-economical cost worldwide, leading to an increased risk of cardiovascular disease (CVD) and thromboembolic events. These processes are largely mediated by platelet activation and endothelial dysfunction. Current anti-diabetic therapies provide limited cardiovascular protection, suggesting that diabetic patie…